Biomarker testing in oncology - Requirements for organizing external quality assessment programs to improve the performance of laboratory testing: revision of an expert opinion paper on behalf of IQNPath ABSL. / (Record no. 1192)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 03752naa a22006257i 4500 |
| 001 - CONTROL NUMBER | |
| control field | UMUN-OA-20261005-MLS-050 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | local |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20261005174905.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
| fixed length control field | m o d |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr|||||||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 261005s2020 xx o u000 0 eng d |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1007/s00428-020-02928-z |
| Source of number or code | doi |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (local)EuropePMC:PMC7550230 |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | local |
| Language of cataloging | eng |
| Transcribing agency | local |
| 041 0# - LANGUAGE CODE | |
| Language code of text/sound track or separate title | eng |
| 100 0# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | K Dufraing |
| Relator term | author. |
| 245 10 - TITLE STATEMENT | |
| Title | Biomarker testing in oncology - Requirements for organizing external quality assessment programs to improve the performance of laboratory testing: revision of an expert opinion paper on behalf of IQNPath ABSL. / |
| Statement of responsibility, etc. | K Dufraing; F Fenizia; E Torlakovic [and others]. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Place of production, publication, distribution, manufacture | [Place of publication not identified] : |
| Name of producer, publisher, distributor, manufacturer | [publisher not identified], |
| Date of production, publication, distribution, manufacture, or copyright notice | 2020. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1 online resource (1 article). |
| 336 ## - CONTENT TYPE | |
| Content type term | text |
| Content type code | txt |
| Source | rdacontent |
| 337 ## - MEDIA TYPE | |
| Media type term | computer |
| Media type code | c |
| Source | rdamedia |
| 338 ## - CARRIER TYPE | |
| Carrier type term | online resource |
| Carrier type code | cr |
| Source | rdacarrier |
| 500 ## - GENERAL NOTE | |
| General note | Publication type: Review article. |
| 500 ## - GENERAL NOTE | |
| General note | Linked open-access copy: published version. |
| 506 0# - RESTRICTIONS ON ACCESS NOTE | |
| Terms governing access | Open access; no subscription required for the linked open-access version. |
| Standardized terminology for access restriction | Unrestricted online access |
| Source of term | star |
| 520 3# - SUMMARY, ETC. | |
| Summary, etc. | In personalized medicine, predictive biomarker testing is the basis for an appropriate choice of therapy for patients with cancer. An important tool for laboratories to ensure accurate results is participation in external quality assurance (EQA) programs. Several providers offer predictive EQA programs for different cancer types, test methods, and sample types. In 2013, a guideline was published on the requirements for organizing high-quality EQA programs in molecular pathology. Now, after six years, steps were taken to further harmonize these EQA programs as an initiative by IQNPath ABSL, an umbrella organization founded by various EQA providers. This revision is based on current knowledge, adds recommendations for programs developed for predictive biomarkers by in situ methodologies (immunohistochemistry and in situ hybridization), and emphasized transparency and an evidence-based approach. In addition, this updated version also has the aim to give an overview of current practices from various EQA providers. |
| 540 ## - TERMS GOVERNING USE AND REPRODUCTION NOTE | |
| Terms governing use and reproduction | Creative Commons Attribution. See the linked licence for the applicable terms. |
| Uniform Resource Identifier | <a href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</a> |
| 546 ## - LANGUAGE NOTE | |
| Language note | In English. |
| 588 0# - SOURCE OF DESCRIPTION NOTE | |
| Source of description note | Description generated from Europe PMC bibliographic metadata retrieved on 5 October 2026; full text linked from the source. |
| 590 ## - LOCAL NOTE (RLIN) | |
| Local note | Course allocation: B. Sc. Medical Laboratory Science. |
| 650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Immunohistochemistry |
| 650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Guideline |
| 650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Oncology |
| 650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | in situ Hybridization |
| 650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Molecular Pathology |
| 650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Proficiency Testing |
| 653 ## - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | B. Sc. Medical Laboratory Science |
| 653 ## - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | UMUN open access collection |
| 653 ## - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | laboratory quality |
| 655 #4 - INDEX TERM--GENRE/FORM | |
| Genre/form data or focus term | Review articles. |
| 700 0# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | F Fenizia |
| Relator term | author. |
| 700 0# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | E Torlakovic |
| Relator term | author. |
| 700 0# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | N Wolstenholme |
| Relator term | author. |
| 700 0# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Z C Deans |
| Relator term | author. |
| 700 0# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | E Rouleau |
| Relator term | author. |
| 700 0# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | M Vyberg |
| Relator term | author. |
| 700 0# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | S Parry |
| Relator term | author. |
| 700 0# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | E Schuuring |
| Relator term | author. |
| 700 0# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Elisabeth M C Dequeker |
| Relator term | author. |
| 700 0# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | |
| Relator term | author. |
| 773 0# - HOST ITEM ENTRY | |
| Title | Virchows Archiv : an international journal of pathology |
| Related parts | Vol. 478, no. 3, (2020), pages/article 553-565 |
| International Standard Serial Number | 0945-6317 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://europepmc.org/articles/PMC7550230">https://europepmc.org/articles/PMC7550230</a> |
| Link text | Read open-access publication |
| Public note | Open access. |
| Access status | 0 |
| 884 ## - DESCRIPTION CONVERSION INFORMATION | |
| Conversion process | Course selection and automated MARC21 enrichment from Europe PMC metadata. |
| Conversion date | 20261005 |
| Identifier of source metadata | https://europepmc.org/articles/PMC7550230 |
| Conversion agency | local |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Suppress in OPAC | No |
No items available.